Intralesional interferon alfa for treatment of recurrent lentige maligna of the eyelid in a patient with primary acquired melanosis [1]

Archives of Dermatology

Volumn 136, Issue 11, 2000, Pages 1415-1416

  Carucci, J A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ADULT; CASE REPORT; DISEASE ASSOCIATION; EYELID DISEASE; HUMAN; LETTER; MALE; MALIGNANT LENTIGO; MELANOSIS; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0033755510     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.136.11.1415     Document Type: Letter

References (17)

1. Clinical characterization of primary acquired melanosis
2. Primary acquired melanosis of the conjunctiva in melanoma in situ
3. Lentigo maligna and lentigo maligna melanoma
4. What's new in the treatment of cutaneous melanoma?
5. Advances in cryosurgery during the past decade
6. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma: A follow-up study
7. Surgical treatment of lentigo maligna and lentigo maligna melanoma
8. Treatment of lentigo maligna
9. Radiation therapy for malignant melanoma
10. Azelaic acid: A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders
11. Lentigo maligna of the lateral canthal skin
12. Melanocytic lesions of the eyelid skin
13. Interferon-alpha in malignant and viral diseases: A review
14. The use of interferon-alpha in the treatment of cutaneous melanoma: A review
15. Conjunctival intraepithelial neoplasia
16. Intralesional interferon treatment of lentigo maligna
17. Clearing of melanoma in situ with intralesional interferon alpha in a patient with xeroderma pigmentosum